Bristol Myers Squibb

About

Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.

10001 - max

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: $80M
Industries: Biotechnology,Health Care,Medical,Pharmaceutical
Founded date: Jan 1, 1887
Number Of Employee: 10001 - max
Operating Status: Active
Investor Type: Venture Capital

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products.

The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$80M

Bristol Myers Squibb has raised a total of $80M in funding over 2 rounds. Their latest funding was raised on Feb 21, 2017 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 21, 2017	Post-IPO Equity	$80M	2	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

5

1

Bristol Myers Squibb has made 5 investments. Their most recent investment was on Nov 29, 2022, when Cajal Neuroscience raised $96M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Nov 29, 2022 Cajal Neuroscience	Series A	$96M	Biotechnology	—
Jul 20, 2022 BigHat Biosciences	Series B	$75M	Artificial Intelligence	—
Jun 8, 2022 Owkin	Series B	$50M	Artificial Intelligence	Yes
Jan 25, 2022 Metagenomi	Series B	$175M	Artificial Intelligence	—
May 1, 2012 Pindrop	Seed	$1M	Audio	—